PlumX Metrics
Embed PlumX Metrics

Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm

Psychopharmacology, ISSN: 0033-3158, Vol: 215, Issue: 4, Page: 697-707
2011
  • 34
    Citations
  • 0
    Usage
  • 69
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Rationale Methamphetamine (MA) is an addictive psychostimulant associated with neurocognitive impairment, including inhibitory deficits characterized by a reduced ability to control responses to stimuli. While various domains of inhibition such as exaggerated novelty seeking and perseveration have been assessed in rodents by quantifying activity in open-field tests, similar models have not been utilized in human substance abusers. We recently developed a cross-species translational human open-field paradigm, the human behavior pattern monitor (hBPM), consisting of an unfamiliar room containing novel and engaging objects. Previous work demonstrated that manic bipolar subjects exhibit a disinhibited pattern of behavior in the hBPM characterized by increased object interactions. Objectives In the current study, we examined the effect of MA dependence on inhibitory deficits using this paradigm. hBPM activity and object interactions were quantified in 16 abstinent MA-dependent individuals and 18 matched drugfree comparison subjects. The Wisconsin card sorting task (WCST) and the positive and negative syndrome scale (PANSS) were administered to assess executive function and psychopathology. Results MA-dependent participants exhibited a significant increase in total object interactions, time spent with objects, and perseverative object interactions relative to comparison subjects. Greater object interaction was associated with impaired performance on the WCST, higher PANSS scores, and more frequent MA use in the past year. Conclusions Abstinent MA-dependent individuals exhibited impaired inhibition in the hBPM, displaying increased interaction with novel stimuli. Utilization of this measure may enable assessment of inhibitory deficits relevant to drug-seeking behavior and facilitate development of intervention methods to reduce high-risk conduct in this population. © Springer-Verlag 2011.

Bibliographic Details

Brook L. Henry; Arpi Minassian; Jared W. Young; Mark A. Geyer; William Perry; Mandy Van Rhenen; Igor Grant; Scott Letendre; Ronald J. Ellis; Christian Achim; Steven Woods; Sara Ortiz; Melanie Sherman; Rachel Schrier; Will Toperoff; Alana Talob; Michael Potter; Edmund Capparelli; D. Pharm; Jennifer Marquie-Beck; Robert Heaton; Terry Alexander; J. Hampton Atkinson; Mariana Cherner; Thomas Marcotte; Nichole Duarte; Mili Parikh; Rachel Meyer; Adam Aron; Matthew Dawson; Gregory Brown; Sarah Archibald; Anders Dale; C. Fenema-Notestine; Terry Jernigan; Thomas Liu; Miriam Scadeng; Brad Beyenhof; Dexter Walpole; Eliezer Masliah; Ian Everall; Stuart Lipton; Virawudh Soontornniyomkij; Erick Tatro; Amir Sabouri; Michael Mante; Dongxian Zhang; Mahalah Buell; Amanda Grethe; Martin Paulus; Sheldon Morris; David Smith; Dee Dee Pacheco; Svetlana Semenova; Athina Markou; Marcus Kaul; Rodney Von Jaeger; Teresa Oyos; Terence Hendrix; Richard Seghers; Anthony C. Gamst; Clint Cushman; Michael Repinski; Jose Mendez; Ian Abramson; Christopher Ake; Reena Deutsch; Florin Vaida

Springer Science and Business Media LLC

Pharmacology, Toxicology and Pharmaceutics

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know